SlideShare una empresa de Scribd logo
1 de 43
Descargar para leer sin conexión
Pharmacokinetics of oral
absorption
Md. Rakibul Hasan
Department of Pharmacy
International Islamic University
Chittagong
• Systemic drug absorption from GI tract/other
extravascular site depend on:
- Physicochemical properties of drug
-dosage form used
- Anatomy and physiology of absorption site
• Oral dosing, factors effect the rate and extent
of drug absorption:
- Surface area of GI tract
- Stomach emptying rate
- GI mobility
- Blood flow to absorption site
• Rate of change in the amount of drug in the
body, dDB/dt = dependent on relative rates of
drug absorption and elimination
• The net rate of drug accumulation in the body:
Plasma level-time curve of drug absorption and
elimination rate processes
Absorption phase- rate of drug
absorption greater than rate of drug
elimination
Elimination occurs whenever drug
present- even though absorption
predominates
At peak drug conc in plasma:
Immediately after time of peak
drug absorption, some drug may
still be at absorption site ( e.g. GI
tract.
Rate of drug elimination is
faster than rate of absorption-
postabsorption phase.
Drug at absorption site- depleted, rate
of absorption approaches 0, dDGI/dt=0
(now elimination phase)- represents
only the elimination of drug from the
body- 1st order process.
Elimination phase- rate of change in
the amount of drug in the body-
described as 1st order process
Zero-order absorption model
• Zero-order absorption- when drug is absorbed
by saturable process/ zero order controlled
release system
• DGI- absorbed systemically at a constant rate,
k0. drug- immediately/simultaneously
eliminated from body by 1st order process-
defined by 1st order rate constant, k.
• Rate of 1st order elimination, at any time:
• Rate of input = ko. ∴, net change per unit time
in the body:
• Integration of this equation, substitute DB=
VDCP:
• Rate of drug absorption, remain constant until
DGI depleted. Time for complete drug
absorption = DGI/ko. After this time, drug is not
available for absorption from gut, equation 1-
not valid. Drug conc in plasma- decline
according to 1st order process.
(1)
First-order absorption model
• Absorption- assume to be 1st order.
• Applies mostly to oral absorption of drugs in
solution/ rapidly dissolving dosage (tablets,
capsules)
• Oral drug- disintegrate of dosage form (if
solid)- drug dissolves into fluid of GI tract.
• Only drug in solution- absorbed in body
• Rate of disappearance of drug from GI:
- ka- 1st order absorption rate constant from GI
- F- fraction absorbed
- DGI- amount of drug in GI at any time, t.
• Integration of above equation,
• Rate of drug change in the body:
• =
• Drug in GI- 1st order decline (i.e. drug is
absorbed across GI wall), amount of drug in GI
at any time, t = D0e-kat.
• Value of F- vary from 0 (drug completely
unabsorbed) to 1 (fully absorbed).
• Integrate the equation- oral absorption
equation- to calculate drug conc (Cp) in plasma
at any time, t:
(2)
plasma level-time curve for drug given in
single dose
•Max plasma conc after oral dosing –
Cmax
•Time needed to reach max conc- tmax
•tmax- independent of dose, dependent
on rate constant for absorption, ka and
elimination, k
•At Cmax- peak conc
•Rate of drug absorbed= rate of drug
eliminated
•Net rate of conc change = 0
•At Cmax- rate of conc change:
Can be simplified:
(3)
(4)
• In order to calculate Cmax- the value of tmax is
determine by equation (4) and substitute to
equation (2).
• Equation (2)- Cmax is proportional to dose of
drug given (Do) and F.
• Elimination rate constant, k- may determined
from elimination phase of plasma level-time
curve.
• At later time intervals, when drug absorption
completed, e-kat ≈ 0, equation 2 reduce to
• ln this equation:
• Substitute to log:
(5)
• With equation (5), graph constructed by
plotting log Cp vs. t will yield straight line with
a slope of –k/2.3
• With similar approach, urinary drug excretion
data may be used for calculation of first-order
elimination rate constant, k
• Rate of drug excretion after single oral dose
drug:
• dDu/dt= rate of urinary drug excretion
- Ke = 1st order renal excretion constant
- F = fraction of dose absorbed
(6)
• Graph constructed by plotting dDu/dt vs. t,
yield curve identical to plasma level-time
curve
• After drug absorption virtually complete, -e-kat
approaches zero, equation (6) reduces to
• Taking ln of both sides, substitute for log
• When log (dDu/dt) vs. t, graph of straight line
is obtained with slope of –k/2.3.
• To obtain the cumulative drug excretion in
urine:
• Plot of Du vs t- give urinary drug excretion
curve.
Cumulative urinary drug excretion vs t, single oral
dose. Urine samples are collected at various time
period.
The amount of drug excreted in each sample is
added to amount of drug recovered in previous
urine sample. Total amount of drug recovered after
all drug excreted is Du∞
Du∞- max amount of active drug excreted
Determination of Absorption rate
constants from oral Absorption data
Method of residuals
• Assume ka>> k in equation (2), the value of 2nd
exponential will become significantly small (e-
kat ≈0)- can be omitted. When this happen=
drug absorption is virtually complete.
• From this, can obtain the intercept at y-axis
• Value of ka can be obtained by using the
method of residuals as described in chapter
before.
• If drug absorption begins
Immediately after oral admin
the residual lines obtained
will intercept on the y axis at
point A
Lag time
• sometimes, absorption of drug after single
dose does not start immediately, due to:
- Physiologic factors (stomach-emptying time
and intestinal motility)
- Time delay prior to commencement of 1st
order drug absorption- lag time
•Lag time- if 2 residual lines obtained by
feathering intersect at point greater than
t=0.
•Lag time t0- beginning of drug absorption.
•Equation to describe lag time:
Second expression that describes the
curve omits lag time:
Determination of ka by plotting % of
drug unabsorbed vs. time (Wagner-
Nelson)
• After single oral dose:
• Ab = DB + Du = amount of drug absorbed
• Ab∞= amount of drug absorbed at t= ∞
• Amount of drug excreted at any time t:
• DB, at any time = CpVD. At any time t, Ab is
• At t = ∞, Cp
∞= 0 (i.e. plasma conc is
neglectable), total amount of drug absorbed:
• Fraction of drug absorbed at any time
• Fraction unabsorbed at any time is
• Drug remaining in GI at any time, t:
• Therefore, fraction of drug remaining
• DGI/D0 = fraction of drug unabsorbed = 1-(Ab/Ab∞)
• Plot of 1-(Ab/Ab∞) vs. t gives slope = -ka/2.3
• The following steps use in determination of ka:
1. Plot log conc of drug vs. t
2. Find k from terminal part of slope, -k/2.3
3. Find [AUC]t0
4. Find k[AUC]t0 by multiplying each [AUC]t0 by k
5. Find [AUC]∞0 by adding up all the [AUC], from t=0 to t=∞
6. Determine 1-(Ab/Ab∞) value corresponding to each time
point t
7. Plot 1-(Ab/Ab∞) vs. t
Fraction of drug uabsorbed vs time using Wagner-
Nelson method
•If fraction of drug unabsorbed,
gives linear line, then rate of drug
absorption, dDGI/dt- 1st order process
•Drug approaches 100% absorption,
Cp- becomes small- the terminal part
become scattered- not included for
estimation of slope.
1-(Ab/Ab∞)
Estimation of ka from urinary data
• Absorption rate constant, ka- can be estimated from
urinary excretion data- %of drug unabsorbed vs time.
• For one-compartment model:
- Ab= total amount of drug absorbed
- DB= amount of drug in body
- Du= amount of unchanged drug excreted from urine
- Cp= plasma drug conc
- DE= total amount of drug eliminated
- Ab= DB + DE
• Differential equation for Ab= DB + DE:
• Assuming 1st order elimination with renal
elimination constant ke:
• Assuming one-compartment model:
(7)
• Substitute VDCP into equation (7):
• Rearrange:
• Substitute dCp/dt into equation (8) and kDu/ke
for DE:
(8)
(9)
• Integrate equation (9) from 0 to t:
• At t=∞ all drug is absorbed, expressed as Ab∞
and dDu/dt=0. total amount of drug absorbed
is:
• Du∞= total amount of unchanged drug
excreted in urine
• Fraction of drug absorbed at any time t=
Abt/Ab∞.
• Plot of fraction of drug unabsorbed, 1-Ab/Ab∞
vs t gives slope = -ka/2.3, in which absorption
rate constant, ka obtained.
Determination of ka from two-
compartment oral absorption data
(Loo-Riegelman method)
• After oral administration of a dose of drug
exhibit two-compartment model, amount of
drug absorbed, Ab:
• Each can be expressed as:
• Substitute the above expression for Dp and
Du:
• Divide the above equation with Vp to express
the equation on drug conc:
• At t=∞, this equation become
(10)
(11)
• Equation (10) divided by equation (11)-
fraction of drug absorbed at any time:
• Plot of fraction of drug unabsorbed, 1-Ab/Ab∞
vs time gives –ka/2.3 as a slope from which
the value of ka is obtained.
• Cp and k[AUC]t0 calculated from Cp vs time.
• Values for (Dt/Vp) can be approximated by
Loo-Riegelman method:
• Ct = Dt/Vp, apparent tissue conc.
• (Cp)tn-1 = conc of drug at central compartment
for sample n-1.
Cumulative relative fraction absorbed
• Fraction of drug absorbed at any time- can be
summed or cumulated
• From equation , the term Ab/Ab∞
becomes cumulative relative fraction
absorbed (CRFA).
• In the Wegner-Nelson equation, Ab/Ab∞ or
CRFA- eventually equal unity- 100% (even
though drug may not be 100% bioavailable.
Significance of absorption rate
constant
• Overall rate of systemic absorption surrounded
by many rate processes:
- Dissolution of drug
- GI motility (ability to move spontaneously)
- Blood flow
- Transport of drug across capillary membrane to
systemic circulation
• Rate of drug absorption- net result of this
processes
• Calculation of ka- important in designing
multiple-dosage regimen
• Ka and k allows for prediction of peak and
plasma drug conc. following multiple dosing

Más contenido relacionado

La actualidad más candente

Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesisZahid1392
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionAreej Abu Hanieh
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppttenzin jangchuk
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSujit Patel
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMShiv kumar
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorptionAravinda Palyam
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsAmeer Ahmed
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusAreej Abu Hanieh
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionMalla Reddy College of Pharmacy
 
Theories of drug dissolution
Theories of drug dissolutionTheories of drug dissolution
Theories of drug dissolutiontanmay93saha
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Naveen Reddy
 

La actualidad más candente (20)

Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
IVIVC
IVIVCIVIVC
IVIVC
 
Pharmacokinetics of drug absorption
Pharmacokinetics of drug absorptionPharmacokinetics of drug absorption
Pharmacokinetics of drug absorption
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesis
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorption
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppt
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEM
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
Nonlinear Pharmacokinetics
Nonlinear PharmacokineticsNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing Models
 
Bioequivalence Studies
Bioequivalence StudiesBioequivalence Studies
Bioequivalence Studies
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
 
Theories of drug dissolution
Theories of drug dissolutionTheories of drug dissolution
Theories of drug dissolution
 
Dissolution
DissolutionDissolution
Dissolution
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
 

Similar a Pharmacokinetics of Oral Drug Absorption

CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptxSamwel Samwel
 
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugCalculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugShivankan Kakkar
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parametersPawanYadav285
 
Week 4- the two open compartment
Week 4- the two open compartmentWeek 4- the two open compartment
Week 4- the two open compartmentlichlmh
 
kinetics (Lec 2).pptx
kinetics (Lec 2).pptxkinetics (Lec 2).pptx
kinetics (Lec 2).pptxHebaYassin10
 
First order absorption model
First order absorption modelFirst order absorption model
First order absorption modelPapon Paul
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSuvarta Maru
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage formskajal pradhan
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationMalla Reddy College of Pharmacy
 
2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptxjiregna5
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxrameshjanga11
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya Udupa
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics Umesh Yadav
 
Bioavailability studies lecture7
Bioavailability studies lecture7Bioavailability studies lecture7
Bioavailability studies lecture7homebwoi
 

Similar a Pharmacokinetics of Oral Drug Absorption (20)

CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
 
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugCalculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
 
Week 4- the two open compartment
Week 4- the two open compartmentWeek 4- the two open compartment
Week 4- the two open compartment
 
kinetics (Lec 2).pptx
kinetics (Lec 2).pptxkinetics (Lec 2).pptx
kinetics (Lec 2).pptx
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
First order absorption model
First order absorption modelFirst order absorption model
First order absorption model
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage forms
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
 
Pharmacokinetic Models
Pharmacokinetic ModelsPharmacokinetic Models
Pharmacokinetic Models
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parameters
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics
 
Bioavailability studies lecture7
Bioavailability studies lecture7Bioavailability studies lecture7
Bioavailability studies lecture7
 

Último

Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 

Último (20)

Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 

Pharmacokinetics of Oral Drug Absorption

  • 1. Pharmacokinetics of oral absorption Md. Rakibul Hasan Department of Pharmacy International Islamic University Chittagong
  • 2. • Systemic drug absorption from GI tract/other extravascular site depend on: - Physicochemical properties of drug -dosage form used - Anatomy and physiology of absorption site
  • 3. • Oral dosing, factors effect the rate and extent of drug absorption: - Surface area of GI tract - Stomach emptying rate - GI mobility - Blood flow to absorption site
  • 4. • Rate of change in the amount of drug in the body, dDB/dt = dependent on relative rates of drug absorption and elimination • The net rate of drug accumulation in the body:
  • 5. Plasma level-time curve of drug absorption and elimination rate processes Absorption phase- rate of drug absorption greater than rate of drug elimination Elimination occurs whenever drug present- even though absorption predominates At peak drug conc in plasma: Immediately after time of peak drug absorption, some drug may still be at absorption site ( e.g. GI tract. Rate of drug elimination is faster than rate of absorption- postabsorption phase. Drug at absorption site- depleted, rate of absorption approaches 0, dDGI/dt=0 (now elimination phase)- represents only the elimination of drug from the body- 1st order process. Elimination phase- rate of change in the amount of drug in the body- described as 1st order process
  • 6. Zero-order absorption model • Zero-order absorption- when drug is absorbed by saturable process/ zero order controlled release system • DGI- absorbed systemically at a constant rate, k0. drug- immediately/simultaneously eliminated from body by 1st order process- defined by 1st order rate constant, k.
  • 7. • Rate of 1st order elimination, at any time: • Rate of input = ko. ∴, net change per unit time in the body: • Integration of this equation, substitute DB= VDCP: • Rate of drug absorption, remain constant until DGI depleted. Time for complete drug absorption = DGI/ko. After this time, drug is not available for absorption from gut, equation 1- not valid. Drug conc in plasma- decline according to 1st order process. (1)
  • 8. First-order absorption model • Absorption- assume to be 1st order. • Applies mostly to oral absorption of drugs in solution/ rapidly dissolving dosage (tablets, capsules) • Oral drug- disintegrate of dosage form (if solid)- drug dissolves into fluid of GI tract. • Only drug in solution- absorbed in body
  • 9. • Rate of disappearance of drug from GI: - ka- 1st order absorption rate constant from GI - F- fraction absorbed - DGI- amount of drug in GI at any time, t. • Integration of above equation,
  • 10. • Rate of drug change in the body: • = • Drug in GI- 1st order decline (i.e. drug is absorbed across GI wall), amount of drug in GI at any time, t = D0e-kat. • Value of F- vary from 0 (drug completely unabsorbed) to 1 (fully absorbed).
  • 11. • Integrate the equation- oral absorption equation- to calculate drug conc (Cp) in plasma at any time, t: (2)
  • 12. plasma level-time curve for drug given in single dose •Max plasma conc after oral dosing – Cmax •Time needed to reach max conc- tmax •tmax- independent of dose, dependent on rate constant for absorption, ka and elimination, k •At Cmax- peak conc •Rate of drug absorbed= rate of drug eliminated •Net rate of conc change = 0 •At Cmax- rate of conc change: Can be simplified: (3) (4)
  • 13. • In order to calculate Cmax- the value of tmax is determine by equation (4) and substitute to equation (2). • Equation (2)- Cmax is proportional to dose of drug given (Do) and F. • Elimination rate constant, k- may determined from elimination phase of plasma level-time curve.
  • 14. • At later time intervals, when drug absorption completed, e-kat ≈ 0, equation 2 reduce to • ln this equation: • Substitute to log: (5)
  • 15. • With equation (5), graph constructed by plotting log Cp vs. t will yield straight line with a slope of –k/2.3
  • 16. • With similar approach, urinary drug excretion data may be used for calculation of first-order elimination rate constant, k • Rate of drug excretion after single oral dose drug: • dDu/dt= rate of urinary drug excretion - Ke = 1st order renal excretion constant - F = fraction of dose absorbed (6)
  • 17. • Graph constructed by plotting dDu/dt vs. t, yield curve identical to plasma level-time curve
  • 18. • After drug absorption virtually complete, -e-kat approaches zero, equation (6) reduces to • Taking ln of both sides, substitute for log • When log (dDu/dt) vs. t, graph of straight line is obtained with slope of –k/2.3. • To obtain the cumulative drug excretion in urine:
  • 19. • Plot of Du vs t- give urinary drug excretion curve. Cumulative urinary drug excretion vs t, single oral dose. Urine samples are collected at various time period. The amount of drug excreted in each sample is added to amount of drug recovered in previous urine sample. Total amount of drug recovered after all drug excreted is Du∞ Du∞- max amount of active drug excreted
  • 20. Determination of Absorption rate constants from oral Absorption data Method of residuals • Assume ka>> k in equation (2), the value of 2nd exponential will become significantly small (e- kat ≈0)- can be omitted. When this happen= drug absorption is virtually complete.
  • 21. • From this, can obtain the intercept at y-axis
  • 22. • Value of ka can be obtained by using the method of residuals as described in chapter before. • If drug absorption begins Immediately after oral admin the residual lines obtained will intercept on the y axis at point A
  • 23. Lag time • sometimes, absorption of drug after single dose does not start immediately, due to: - Physiologic factors (stomach-emptying time and intestinal motility) - Time delay prior to commencement of 1st order drug absorption- lag time
  • 24. •Lag time- if 2 residual lines obtained by feathering intersect at point greater than t=0. •Lag time t0- beginning of drug absorption. •Equation to describe lag time: Second expression that describes the curve omits lag time:
  • 25. Determination of ka by plotting % of drug unabsorbed vs. time (Wagner- Nelson) • After single oral dose: • Ab = DB + Du = amount of drug absorbed • Ab∞= amount of drug absorbed at t= ∞ • Amount of drug excreted at any time t: • DB, at any time = CpVD. At any time t, Ab is
  • 26. • At t = ∞, Cp ∞= 0 (i.e. plasma conc is neglectable), total amount of drug absorbed: • Fraction of drug absorbed at any time
  • 27. • Fraction unabsorbed at any time is • Drug remaining in GI at any time, t: • Therefore, fraction of drug remaining
  • 28. • DGI/D0 = fraction of drug unabsorbed = 1-(Ab/Ab∞) • Plot of 1-(Ab/Ab∞) vs. t gives slope = -ka/2.3 • The following steps use in determination of ka: 1. Plot log conc of drug vs. t 2. Find k from terminal part of slope, -k/2.3 3. Find [AUC]t0 4. Find k[AUC]t0 by multiplying each [AUC]t0 by k 5. Find [AUC]∞0 by adding up all the [AUC], from t=0 to t=∞ 6. Determine 1-(Ab/Ab∞) value corresponding to each time point t 7. Plot 1-(Ab/Ab∞) vs. t
  • 29.
  • 30. Fraction of drug uabsorbed vs time using Wagner- Nelson method •If fraction of drug unabsorbed, gives linear line, then rate of drug absorption, dDGI/dt- 1st order process •Drug approaches 100% absorption, Cp- becomes small- the terminal part become scattered- not included for estimation of slope. 1-(Ab/Ab∞)
  • 31. Estimation of ka from urinary data • Absorption rate constant, ka- can be estimated from urinary excretion data- %of drug unabsorbed vs time. • For one-compartment model: - Ab= total amount of drug absorbed - DB= amount of drug in body - Du= amount of unchanged drug excreted from urine - Cp= plasma drug conc - DE= total amount of drug eliminated - Ab= DB + DE
  • 32. • Differential equation for Ab= DB + DE: • Assuming 1st order elimination with renal elimination constant ke: • Assuming one-compartment model: (7)
  • 33. • Substitute VDCP into equation (7): • Rearrange: • Substitute dCp/dt into equation (8) and kDu/ke for DE: (8) (9)
  • 34. • Integrate equation (9) from 0 to t: • At t=∞ all drug is absorbed, expressed as Ab∞ and dDu/dt=0. total amount of drug absorbed is: • Du∞= total amount of unchanged drug excreted in urine
  • 35. • Fraction of drug absorbed at any time t= Abt/Ab∞. • Plot of fraction of drug unabsorbed, 1-Ab/Ab∞ vs t gives slope = -ka/2.3, in which absorption rate constant, ka obtained.
  • 36. Determination of ka from two- compartment oral absorption data (Loo-Riegelman method) • After oral administration of a dose of drug exhibit two-compartment model, amount of drug absorbed, Ab: • Each can be expressed as:
  • 37. • Substitute the above expression for Dp and Du: • Divide the above equation with Vp to express the equation on drug conc: • At t=∞, this equation become (10) (11)
  • 38. • Equation (10) divided by equation (11)- fraction of drug absorbed at any time: • Plot of fraction of drug unabsorbed, 1-Ab/Ab∞ vs time gives –ka/2.3 as a slope from which the value of ka is obtained.
  • 39. • Cp and k[AUC]t0 calculated from Cp vs time. • Values for (Dt/Vp) can be approximated by Loo-Riegelman method: • Ct = Dt/Vp, apparent tissue conc. • (Cp)tn-1 = conc of drug at central compartment for sample n-1.
  • 40. Cumulative relative fraction absorbed • Fraction of drug absorbed at any time- can be summed or cumulated • From equation , the term Ab/Ab∞ becomes cumulative relative fraction absorbed (CRFA).
  • 41. • In the Wegner-Nelson equation, Ab/Ab∞ or CRFA- eventually equal unity- 100% (even though drug may not be 100% bioavailable.
  • 42. Significance of absorption rate constant • Overall rate of systemic absorption surrounded by many rate processes: - Dissolution of drug - GI motility (ability to move spontaneously) - Blood flow - Transport of drug across capillary membrane to systemic circulation • Rate of drug absorption- net result of this processes
  • 43. • Calculation of ka- important in designing multiple-dosage regimen • Ka and k allows for prediction of peak and plasma drug conc. following multiple dosing